Department of Digestive and Hepatobiliary Surgery, Assistance Publique-Hôpitaux de Paris, Henri Mondor University Hospital, Créteil, France.
Br J Surg. 2010 Sep;97(9):1354-62. doi: 10.1002/bjs.7128.
This study assessed the feasibility and outcomes of combined colorectal and hepatic resection as the first step of two-stage hepatectomy in patients with bilobar synchronous colorectal liver metastases.
All patients with bilobar synchronous colorectal liver metastases who were considered for two-stage hepatectomy, combining resection of the primary tumour with the first stage of hepatectomy, between 2000 and 2008 were selected from a prospectively collected database at two institutions. Data were analysed retrospectively on an intention-to-treat basis.
Thirty-three patients were studied. Twenty patients received neoadjuvant chemotherapy. Combined colorectal resection and clearance of left-sided liver metastases was the first-stage procedure in all but one patient, in whom right clearance was performed. In 17 patients right portal vein ligation was undertaken at the same time. No patient died. Two patients had anastomotic leakage. Interval chemotherapy was given to 25 patients, five of whom also had percutaneous portal vein embolization. Twenty-five patients had the second-stage hepatectomy, but not eight patients with disease progression. There was one postoperative death after the second stage, and eight patients experienced morbidity. Median follow-up from the first stage was 28.7 months. Overall and disease-free survival rates for patients who completed the procedure were 80 and 44 per cent respectively at 3 years, and 48 and 22 per cent at 5 years.
In patients with bilobar synchronous colorectal liver metastases who are candidates for two-stage hepatectomy, combined resection of the primary tumour and first-stage hepatectomy reduces the number of procedures, optimizes chemotherapy administration and may improve outcome.
本研究评估了联合结直肠和肝脏切除术作为两阶段肝切除术的第一步在双侧同步结直肠肝转移患者中的可行性和结果。
从两个机构的前瞻性收集数据库中选择了 2000 年至 2008 年间所有考虑行两阶段肝切除术(联合切除原发肿瘤和第一阶段肝切除术)的双侧同步结直肠肝转移患者。根据意向治疗原则进行回顾性数据分析。
研究了 33 名患者。20 名患者接受了新辅助化疗。除了一名患者接受右肝切除外,所有患者均接受了联合结直肠切除术和左半肝转移灶清除术。在 17 名患者中,同时进行了右门静脉结扎术。没有患者死亡。两名患者发生吻合口漏。25 名患者接受了间隔化疗,其中 5 名患者还接受了经皮门静脉栓塞术。25 名患者接受了第二阶段肝切除术,但 8 名患者因疾病进展而无法进行手术。第二阶段手术后有 1 例死亡,8 例患者出现并发症。从第一阶段开始的中位随访时间为 28.7 个月。完成手术的患者的总体生存率和无病生存率分别为 3 年时的 80%和 44%,5 年时的 48%和 22%。
对于适合两阶段肝切除术的双侧同步结直肠肝转移患者,联合切除原发肿瘤和第一阶段肝切除术可减少手术次数,优化化疗管理,可能改善预后。